Cargando…
Proteomic Analysis of Breast Cancer Resistance to the Anticancer Drug RH1 Reveals the Importance of Cancer Stem Cells
Antitumor drug resistance remains a major challenge in cancer chemotherapy. Here we investigated the mechanism of acquired resistance to a novel anticancer agent RH1 designed to be activated in cancer cells by the NQO1 enzyme. Data show that in some cancer cells RH1 may act in an NQO1-independent wa...
Autores principales: | Kuciauskas, Dalius, Dreize, Nadezda, Ger, Marija, Kaupinis, Algirdas, Zemaitis, Kristijonas, Stankevicius, Vaidotas, Suziedelis, Kestutis, Cicenas, Jonas, Graves, Lee M., Valius, Mindaugas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6678540/ https://www.ncbi.nlm.nih.gov/pubmed/31336714 http://dx.doi.org/10.3390/cancers11070972 |
Ejemplares similares
-
Molecular Insights into miRNA-Driven Resistance to 5-Fluorouracil and Oxaliplatin Chemotherapy: miR-23b Modulates the Epithelial–Mesenchymal Transition of Colorectal Cancer Cells
por: Gasiulė, Stasė, et al.
Publicado: (2019) -
Uptake
of Upconverting Nanoparticles by Breast Cancer
Cells: Surface Coating versus the Protein Corona
por: Voronovic, Evelina, et al.
Publicado: (2021) -
CEACAM6’s Role as a Chemoresistance and Prognostic Biomarker for Pancreatic Cancer: A Comparison of CEACAM6’s Diagnostic and Prognostic Capabilities with Those of CA19-9 and CEA
por: Kurlinkus, Benediktas, et al.
Publicado: (2021) -
Highlights of the Latest Advances in Research on CDK Inhibitors
por: Cicenas, Jonas, et al.
Publicado: (2014) -
Interaction between Phage T4 Protein RIII and Host Ribosomal Protein S1 Inhibits Endoribonuclease RegB Activation
por: Juškauskas, Augustinas, et al.
Publicado: (2022)